Skip to content
DefDex

Federal award

BIOCARE MEDICAL LLC

W91YTZ10P0364

Contract

Obligated and Ceiling

Obligated (net)
$895,653.44
Ceiling (potential value, not spending)
$1,135,057.39
Current value
$895,653.44
Gross positive obligations
$991,410.05

Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.

Award Details

Recipient
BIOCARE MEDICAL LLC · MS7LZ6JPYNQ5
Owner company
Not a reviewed companyNo reviewed company owns this recipient.
Reported parent
BIOCARE MEDICAL LLC · MS7LZ6JPYNQ5
Awarding agency
Department of War · sub-agency 2100 · office W81K04
Funding agency
Department of War · sub-agency 2100
Product or service (PSC)
6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS
Industry (NAICS)
325413 · IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING
PIID
W91YTZ10P0364
Award type code
B
Actions
19 · May 3, 2010 to Jul 19, 2018
Why it is listed
gross positive obligations of $100k or more (contracts)

Open this award on USAspending →

Action History19

Award actions
DateFYModAction typeObligationCompany in company totals
Jul 19, 2018FY2018P00019F−$66,112.67
—
Sep 21, 2017FY2017P00018K−$29,643.94
—
Sep 28, 2015FY2015P00017M$3,775.59
—
May 2, 2014FY2014P00016G$258,105.58
—
May 1, 2014FY2014P00015D$0.00
—
Jun 28, 2013FY2013P00013M$0.00
—
Apr 26, 2013FY2013P00012G$212,276.49
—
Apr 11, 2013FY2013P00011M$0.00
—
Mar 27, 2013FY2013P00010M$0.00
—
Sep 25, 2012FY2012P00009M$6,600.00
—
Jul 23, 2012FY2012P00008M$16,502.57
—
Mar 13, 2012FY2012P00007M$0.00
—
Jan 29, 2012FY2012P00006G$162,705.63
—
Dec 20, 2011FY2012P00005M$0.00
—
Jul 5, 2011FY2011P00004G$156,875.67
—
Apr 29, 2011FY2011P00003F$23,262.80
—
Jan 31, 2011FY2011P00002C$38,845.22
—
Aug 3, 2010FY2010P00001M$32,474.74
—
May 3, 2010FY20100—$79,985.76
—

Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.